Hydrochlorothiazide Use and Risk of Skin Cancer: A Population-Based Retrospective Cohort Study.

MLA

Yang, Avery Shuei-He, et al. “Hydrochlorothiazide Use and Risk of Skin Cancer: A Population-Based Retrospective Cohort Study.” Pharmacoepidemiology and Drug Safety, vol. 33, no. 11, Nov. 2024, p. e70027. EBSCOhost, https://doi.org/10.1002/pds.70027.

APA

Yang, A. S.-H., Djebarri, L., Lee, C. N., Granados, D., Moneim, M. A., Shao, S.-C., Lin, S.-J., Liao, T.-C., Lin, H.-W., & Lai, E. C.-C. (2024). Hydrochlorothiazide Use and Risk of Skin Cancer: A Population-Based Retrospective Cohort Study. Pharmacoepidemiology and Drug Safety, 33(11), e70027. https://doi.org/10.1002/pds.70027

Chicago

Yang, Avery Shuei-He, Leila Djebarri, Chaw Ning Lee, Denis Granados, Mohamed Abdel Moneim, Shih-Chieh Shao, Swu-Jane Lin, Tzu-Chi Liao, Hung-Wei Lin, and Edward Chia-Cheng Lai. 2024. “Hydrochlorothiazide Use and Risk of Skin Cancer: A Population-Based Retrospective Cohort Study.” Pharmacoepidemiology and Drug Safety 33 (11): e70027. doi:10.1002/pds.70027.